The Future of HIV-1 Therapeutics
Resistance Is Futile?
- (view affiliations)
Highlights the identification and evaluation of antiretrovirals that may be less prone in selecting for HIV-1 resistance
Covers recent advances in the identification and function of small molecule inhibitors that target novel HIV-1 regulatory and structural components to disrupt replication and alter the state of viral latency
Offers up-to-date information for virologists, infectious disease specialists, and chemical biologists on HIV-1 antiretrovirals currently in use
- 24k Downloads
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 389)